help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giusti, V.
Right arrow Articles by Pralong, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giusti, V.
Right arrow Articles by Pralong, F. P.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 3 1379-1384
Copyright © 2004 by The Endocrine Society

Molecular Determinants of Human Adipose Tissue: Differences between Visceral and Subcutaneous Compartments in Obese Women

V. Giusti, M. Suter, C. Verdumo, R. C. Gaillard, P. Burckhardt and F. P. Pralong

Departments of Internal Medicine (V.G., C.V., P.B.) and Surgery (M.S.) and Division of Endocrinology, Diabetology, and Metabolism (R.C.G., F.P.P.), Centre Hospitalier Universitaire Vaudois, Lausanne, 1011 Switzerland

Address all correspondence and requests for reprints to: Vittorio Giusti, M.D., Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. E-mail: vittorio.giusti{at}chuv.hospvd.ch.

The adipose tissue is playing an important role in the development of human obesity and its related comorbidities, but little is known about the mechanisms governing its differentiation and proliferation. In this work, we studied the expression of transcription factors involved in fat storage and metabolic regulations in adipose tissue of 50 well-characterized obese women. In multivariate analyses, 80% of c enhancer binding protein {alpha} (cEBP{alpha}), c and a sterol regulatory element binding protein 1 (c and a SREBP1), and retinoid X receptor (RXR{alpha}) levels in sc adipose tissue (SAT) could be explained by other transcription factors. In addition, RXR{alpha} was the major determinant of peroxisome proliferator and activated receptor-{gamma}1 variability in SAT, with the two factors being involved in the determination of the variability of insulin resistance. In contrast, the levels of all these transcription factors, together with various phenotypic and biological characteristics of the patients, seemed to participate only marginally in the regulation of visceral adipose tissue activity. In similar multivariate analyses, they could explain only a minor part of the variability of cEBP{alpha}, c and a SREBP1, or RXR{alpha}, suggesting the involvement of other regulators. Overall, our results demonstrate a different regulation of visceral adipose tissue and SAT and a different role of both tissues in insulin resistance and lipid storage.

Abbreviations: aSREBP1, cSREBP1, a and c Sterol regulatory element binding protein 1; BMI, body mass index; cEBP{alpha}, enhancer binding protein {alpha}; HOMA, homeostasis model assessment; PGC1, PPAR-{gamma} coactivator 1; PPAR, peroxisome proliferator and activated receptor; RXR{alpha}, retinoid X receptor {alpha}; SAT, sc adipose tissue; VAT, visceral adipose tissue.




This article has been cited by other articles:


Home page
CirculationHome page
C. S. Fox, J. M. Massaro, U. Hoffmann, K. M. Pou, P. Maurovich-Horvat, C.-Y. Liu, R. S. Vasan, J. M. Murabito, J. B. Meigs, L. A. Cupples, et al.
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study
Circulation, July 3, 2007; 116(1): 39 - 48.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Chau-Van, M. Gamba, R. Salvi, R. C. Gaillard, and F. P. Pralong
Metformin Inhibits Adenosine 5'-Monophosphate-Activated Kinase Activation and Prevents Increases in Neuropeptide Y Expression in Cultured Hypothalamic Neurons
Endocrinology, February 1, 2007; 148(2): 507 - 511.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society